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Introduction
Two major immuno-inflammatory phases are well docu-
mented during sepsis: an early active inflammatory
phase regulated followed by a deactivated inflammatory
phase leading to immunosuppression. Innate immunity,
such as monocyte HLA-DR expression (mHLA-DR), has
been shown constantly and rapidly decreased. Adaptive
immunity modifications have been reported, this
appeared less documented, particularly in comparison
with healthy volunteers which have been rarely reported.
Objectives
The aim of this study is 1- to describe lymphocyte phe-
notypes in healthy volunteers 2- to study the phenotype
in early (< D7) and late (>D7) phases of severe sepsis 3-
to test the relation between lymphocyte phenotypes and
prognosis.
Methods
Monocenter study on patients with severe sepsis and
septic shock. Data recorded: demographic, clinical sever-
ity, blood cell count, mHLA-DR, lymphocyte phenotype
(flow cytometry, CD3+, CD3+CD4+, CD3+CD8+, CD19
+, CD16+CD56+). Samples taken as part of routine care
without additional blood collection and did not required
patient´s consent. Patients data compared with a histori-
cal group of healthy volunteers from the laboratory.
Statistics: results expressed as median (25th-75th percen-
tile), Mann-Whitney test, Pearson correlation.
Results
45 septic patients (9 severe sepsis, 36 septic shock), age
66 (52-85), sex (29M/16F), origin of sepsis (pulmonary
30%, abdominal 35%, others 30%), SAPS2 at admission
51 (40-63), SOFA score (day of phenotype) 9 (5-13),
overall mortality at day 7: 22% and day 28: 48%, delay
between the inflammatory insult and lymphocyte pheno-
type was 2 days (1-10). 48 healthy volunteers in the con-
trol group: age 42 (31-55), sex (24M/24F). The overall
lymphopenia in septic patients was -37% compared to
controls, mainly due to CD4 T lymphocytes depletion
(Table). This T lymphopenia was more marked in the
early phase (< 7D) than in the late phase (>7D) (p =
0.006). Early lymphocyte phenotype was not associated
with mortality at day 7; as was not late lymphocyte phe-
notype with mortality at day 28. There was a correlation
between lymphopenia and mHLA-DR (r0.55, p0.00009).
There was no correlation between lymphocyte pheno-
type and severity scores.
Conclusions
In severe sepsis including shock, lymphopenia was predo-
minant on CD4+ T lymphocytes, mainly at the early
phase, in association with decreased expression of
mHLA-DR, suggesting synergistic changes in innate and
adaptive immunity. Such monitoring for innate and
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1586 (1372-1991) 1000 (660-1495) 0.12
T Lymphocytes
CD3+
1182 (949-1524) 609 (258-1038) < 0.05*
CD3+CD4+ 685 (595-1035) 378 (156-668) < 0.05*
CD3+CD8+ 431 (301-508) 200 (90-338) 0.33
B Lymphocytes
CD19+
143 (96-338) 149 (75-252) 0.14
NK CD16+CD56+ 161 (114-268) 161 (114-268) 0.83
mHLA-DR (AB/C) 39970 (35480-46480) 5700 (3545-10072) < 0.05*
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adaptive immunity may help to decide the suitable drug
to boost immunity, such as IFNg or IL-7.
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